Brooktree Capital Management Novartis Ag Transaction History

Brooktree Capital Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$81.78 - $95.14 $207,884 - $241,845	-2,542 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$83.5 - $98.47 $444,804 - $524,549	-5,327 Reduced 67.7%	2,542 $217,000
Q4 2020 Feb 03, 2021	SELL	$78.07 - $94.43 $32,789 - $39,660	-420 Reduced 5.07%	7,869 $743,000
Q3 2020 Nov 09, 2020	SELL	$82.14 - $91.0 $4,107 - $4,550	-50 Reduced 0.6%	8,289 $720,000
Q2 2020 Aug 03, 2020	SELL	$80.93 - $91.1 $96,306 - $108,409	-1,190 Reduced 12.49%	8,339 $728,000
Q1 2020 May 06, 2020	SELL	$70.67 - $99.01 $13,073 - $18,316	-185 Reduced 1.9%	9,529 $786,000
Q4 2019 Feb 26, 2020	BUY	$84.35 - $95.37 $819,375 - $926,424	9,714 New	9,714 $920,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Brooktree Capital Management, based on Form 13F filings with the SEC.

Stay updated on Brooktree Capital Management with notifications on news.